KFDA to activate bio-equivalent tests.

Published: 2002-08-28 06:57:00

Updated: 2002-08-28 06:57:00

As a result of the strong government determination on the bio-equivalency issue, the top administrator of KFDA and the director of the Drug Safety Bureau confirmed again to activate the bio-equivalent tests

Dr. Lee Young-soon, the administrator of KFDA and Mr. Chang Joon-shik, the director of the Drug Safety Bureau, will directly command all project activation program. For this program, the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.